Zurueck zur Suche

Reporte zur Charge U029324

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 2 ID 1 OR 1

VAERS 2236490

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029324

mild
Staat
ID
Alter
1,0
Geschlecht
F
Eingang
15.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site swelling Irritability Rash

Symptomtext

Later that day on the 4th, R leg started to swell at injection site and by the 7th it was 4cm and sticking up 0.5-1cm in height. On the 13th the swelling in leg was down to the size of a mosquito bite. Then on the 11th she developed a rash on L thigh measuring 1.5cm. Mom states she is always cranky and needy after immunizations, for about 5 days. This is the first time that she has had reactions at the injection sites.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Fluoride drops
Allergien
NKA
Vorherige Impfungen
-

VAERS 2261400

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029324

gering
Staat
OR
Alter
1,0
Geschlecht
F
Eingang
03.05.2022
Impfdatum
12.04.2022
Beginn
12.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

No abnormal signs or symptoms have been reported for this patient; She reports this was a vaccine selection error as the provider intended to administer MMR vaccine instead of Proquad; She reports this was a vaccine selection error as the provider intended to administer MMR vaccine instead of Proquad; patient received 0.5 ml of Varivax and 0.5 ml of Proquad due to vaccine selection error; This spontaneous report was received from a medical assistant and refers to a 12-month-old female patient. The patient's concurrent conditions, concomitant therapies and medical history were not provided. On 12-APR-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) dose of 0.5 ml, subcutaneously in the left thigh, lot # U027947, expiration date was reported as 12-APR-2023 but upon internal validation process it was established as 08-SEP-2023 and measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human albumin (rHA) (PROQUAD) dose of 0.5 ml, subcutaneously in the right thigh, lot # U029324, expiration date 19-MAR-2023, albumin status has been verified as recombinant human albumin (rHA). Both vaccines were administered for prophylaxis. This was a vaccine selection error as the provider intended to administer measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) instead of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD). Administration error was discovered on the evening of 12-APR-2022 (also reported as on 13-APR-2023, discrepant information) after the patient was discharged to home with her parents. No abnormal signs or symptoms have been reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2254036

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029324

gering
Staat
CA
Alter
32,0
Geschlecht
F
Eingang
27.04.2022
Impfdatum
06.04.2022
Beginn
06.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

No other AE; PROQUAD was inadvertently given to a 32-year-old adult on 06April2022.; This spontaneous report was received from a nurse and concerns 32-year-old female patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 06-APR-2022, the patient was inadvertently vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (recombinant human albumin (rHA)) (PROQUAD) 0.5 ml once, lot number: U029324, expiration date: 19-MAR-2023 (strength, route and site of administration were not reported) that was reconstituted in a sterile diluent (strength, dose, lot#, expiration date and route of administration were not provided) for prophylaxis (product administered to patient of inappropriate age). No other adverse event was reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2160519

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029324

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
05.03.2022
Impfdatum
07.02.2022
Beginn
07.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

No additional AE; PROQUAD administered to 14-year-old; This spontaneous report was received from a nurse referring to a 14-year-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, or concomitant medications were not reported. On 07-FEB-2022, the patient was vaccinated with measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (rHA) (PROQUAD) injection, 0.5 milliliters (ml) by subcutaneous route as prophylaxis (lot number U029324 which has been verified to be valid, expiration date reported and validated as 19-MAR-2023) (anatomical site of injection was not reported) (product administered to patient of inappropriate age). No additional adverse events were reported in the patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-